Department of Clinical Sciences

Medicine & Life Sciences

1. HIV 100%
2. Belgium 51%
3. Democratic Republic of the Congo 44%
4. Malaria 42%
5. Ethiopia 36%
6. Visceral Leishmaniasis 34%
7. Tuberculosis 33%
8. Routine Diagnostic Tests 31%
9. Uganda 28%
10. Infection 26%
11. Cambodia 24%
12. Pre-Exposure Prophylaxis 23%
13. HIV Infections 22%
14. Sexually Transmitted Diseases 21%
15. Therapeutics 19%
16. Africa South of the Sahara 18%
17. Sexual and Gender Minorities 18%
18. Neisseria gonorrhoeae 17%
19. HIV-1 16%
20. Syphilis 15%
21. Rwanda 15%
22. Disease Outbreaks 15%
23. Guinea 14%
24. Fever 14%
25. Bacterial Vaginosis 14%
26. South Africa 13%
27. Hepacivirus 13%
28. Population 13%
29. Cohort Studies 13%
30. Coinfection 12%
31. Child 12%
32. Gonorrhea 12%
33. Polymerase Chain Reaction 12%
34. Acquired Immunodeficiency Syndrome 12%
35. Cross-Sectional Studies 12%
36. Parasites 12%
37. Virus Diseases 11%
38. Immune Reconstitution Inflammatory Syndrome 11%
39. CD4 Lymphocyte Count 11%
40. Retrospective Studies 11%
41. Burkina Faso 11%
42. Microscopy 11%
43. Plasmodium falciparum 10%
44. Antigens 10%
45. Blood Culture 10%
46. Viral Load 10%
47. Anti-Bacterial Agents 9%
48. Antibodies 9%
49. Kenya 9%
50. African Trypanosomiasis 9%
51. Health 9%
52. Mortality 9%
53. Income 9%
54. Confidence Intervals 8%
55. Ciprofloxacin 8%
56. Ebola Hemorrhagic Fever 8%
57. Schistosomiasis 8%
58. Rifampin 8%
59. Azithromycin 8%
60. Fluoroquinolones 8%
61. Salmonella 8%
62. Western Africa 8%
63. Macrolides 8%
64. Multidrug-Resistant Tuberculosis 8%
65. Salmonella typhi 8%
66. Guidelines 7%
67. Eastern Africa 7%
68. Peru 7%
69. Enzyme-Linked Immunosorbent Assay 7%
70. Zika Virus 7%
71. Incidence 7%
72. SARS Virus 7%
73. Treponema pallidum 7%
74. Microbiota 7%
75. Genotype 7%
76. Viruses 7%
77. Sexual Behavior 7%
78. Point-of-Care Systems 7%
79. Clinical Trials 7%
80. Treatment Failure 7%
81. Pharmaceutical Preparations 7%
82. Plasmodium 7%
83. Serogroup 7%
84. Zambia 6%
85. Mycoplasma genitalium 6%
86. Epidemics 6%
87. Leishmaniasis 6%
88. Chikungunya virus 6%
89. Typhoid Fever 6%
90. HIV-2 6%
91. Serum 6%
92. Chlamydia trachomatis 6%
93. Sex Workers 6%
94. Safety 6%
95. Gambia 6%
96. Sierra Leone 6%
97. Falciparum Malaria 6%
98. Vaccination 6%
99. Neisseria 6%
100. Hepatitis C 6%